Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone and postoperative bleeding following pediatric tonsillectomy
2021-001425-48Phase 4Terminated
- Sponsor
- Hôpital des Enfants - Hôpitaux universitaires de Genève
- Start
- Mar 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexamethasone in otolaryngological diseases (ENT), sponsored by Hôpital des Enfants - Hôpitaux universitaires de Genève. Primary endpoint: Incidence of postoperative haemorrhage requiring re-operation within 30 days. Started Mar 2021; status: terminated.
02
Drugs
dexamethasone
03
Conditions
otolaryngological diseases (ENT)
Beyond the preview
Go deeper on 2021-001425-48.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001425-48.